1. Home
  2. CMPS vs PHT Comparison

CMPS vs PHT Comparison

Compare CMPS & PHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • PHT
  • Stock Information
  • Founded
  • CMPS 2020
  • PHT 2002
  • Country
  • CMPS United Kingdom
  • PHT United States
  • Employees
  • CMPS N/A
  • PHT N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • PHT Investment Managers
  • Sector
  • CMPS Health Care
  • PHT Finance
  • Exchange
  • CMPS Nasdaq
  • PHT Nasdaq
  • Market Cap
  • CMPS 280.2M
  • PHT 232.7M
  • IPO Year
  • CMPS 2020
  • PHT N/A
  • Fundamental
  • Price
  • CMPS $3.64
  • PHT $7.83
  • Analyst Decision
  • CMPS Strong Buy
  • PHT
  • Analyst Count
  • CMPS 6
  • PHT 0
  • Target Price
  • CMPS $33.60
  • PHT N/A
  • AVG Volume (30 Days)
  • CMPS 1.1M
  • PHT 85.5K
  • Earning Date
  • CMPS 02-27-2025
  • PHT 01-01-0001
  • Dividend Yield
  • CMPS N/A
  • PHT 8.76%
  • EPS Growth
  • CMPS N/A
  • PHT N/A
  • EPS
  • CMPS N/A
  • PHT 0.98
  • Revenue
  • CMPS N/A
  • PHT N/A
  • Revenue This Year
  • CMPS N/A
  • PHT N/A
  • Revenue Next Year
  • CMPS N/A
  • PHT N/A
  • P/E Ratio
  • CMPS N/A
  • PHT $7.71
  • Revenue Growth
  • CMPS N/A
  • PHT N/A
  • 52 Week Low
  • CMPS $3.17
  • PHT $6.41
  • 52 Week High
  • CMPS $12.75
  • PHT $7.60
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 42.17
  • PHT 52.51
  • Support Level
  • CMPS $3.29
  • PHT $7.73
  • Resistance Level
  • CMPS $3.62
  • PHT $7.85
  • Average True Range (ATR)
  • CMPS 0.41
  • PHT 0.06
  • MACD
  • CMPS -0.03
  • PHT 0.01
  • Stochastic Oscillator
  • CMPS 23.11
  • PHT 71.05

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About PHT Pioneer High Income Fund Inc.

Pioneer High Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income and to seek capital appreciation by investing predominantly in below investment grade (high-yield) debt securities, loans, and preferred stocks.

Share on Social Networks: